Petros Pharmaceuticals, Inc.
PTPI
$0.0919
-$0.0106-10.34%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -78.33% | 1.02% | 33.18% | 41.49% | 60.71% |
| Total Receivables | -34.50% | -31.06% | -18.44% | 5.50% | -22.47% |
| Inventory | 22.14% | 30.62% | 34.46% | 53.89% | 16.11% |
| Prepaid Expenses | 71.85% | 113.93% | 174.04% | 136.88% | -74.01% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 89.13% | 76.98% | 37.83% | 1.75% | 8.39% |
| Total Current Assets | -56.11% | 6.30% | 28.76% | 39.01% | 30.16% |
|
|
|||||
| Total Current Assets | -56.11% | 6.30% | 28.76% | 39.01% | 30.16% |
| Net Property, Plant & Equipment | -50.85% | -45.94% | -40.30% | -35.81% | -32.13% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -30.15% | -28.83% | -27.70% | -26.73% | -25.74% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -32.09% | -25.37% | -19.39% | -18.25% | -17.22% |
| Total Assets | -46.82% | -12.38% | -0.84% | 4.24% | 3.23% |
|
|
|||||
| Total Accounts Payable | 18.15% | -55.65% | 15.01% | -5.15% | -34.99% |
| Total Accrued Expenses | 25.12% | -11.11% | 86.28% | 144.10% | 134.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 80.57% | 51.87% | 23.95% | 4.03% | 23.43% |
| Total Finance Division Other Current Liabilities | 85.03% | 95.47% | 107.27% | 67.98% | -19.56% |
| Total Other Current Liabilities | 85.03% | 95.47% | 107.27% | 67.98% | -19.56% |
| Total Current Liabilities | 55.43% | 25.25% | 62.95% | 52.39% | 1.73% |
|
|
|||||
| Total Current Liabilities | 55.43% | 25.25% | 62.95% | 52.39% | 1.73% |
| Long-Term Debt | -32.09% | -25.37% | -19.39% | -18.25% | -17.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -39.37% | -41.19% | -44.99% | -47.58% | -49.57% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -44.83% | 1.27% | 29.73% | 35.61% | 87.38% |
|
|
|||||
| Common Stock & APIC | 0.86% | 2.03% | 3.05% | 3.29% | -0.99% |
| Retained Earnings | -4.76% | -7.45% | -9.71% | -9.00% | -14.68% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -55.06% | -37.65% | -36.65% | -27.73% | -66.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -98.88% | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -98.88% | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -55.06% | -37.65% | -36.65% | -27.73% | -66.50% |
| Total Preferred Equity | -98.88% | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -55.83% | -29.03% | -30.78% | -25.28% | -65.90% |
|
|
|||||
